Immunotherapy for lethal prostate cancer

Nat Rev Urol. 2019 Feb;16(2):69-70. doi: 10.1038/s41585-018-0121-y.

Pasquale Rescigno^{1

2

3}, Johann S de Bono^{4

5}

¹ Division of Clinical Studies, The Institute of Cancer Research, London, UK.
² Prostate Targeted Therapy Group, The Royal Marsden Hospital, London, UK.
³ Department of Clinical Medicine and Surgery, Department of Translational Medical Sciences, AOU Federico II, Naples, Italy.
⁴ Division of Clinical Studies, The Institute of Cancer Research, London, UK. johann.de-bono@icr.ac.uk.
⁵ Prostate Targeted Therapy Group, The Royal Marsden Hospital, London, UK. johann.de-bono@icr.ac.uk.

No abstract available

MeSH terms